Pleased to lead the way, aiming at the global pharmaceutical market.
About TWi Pharmaceuticals USA, Inc.
TWi Pharmaceuticals USA Inc. is a wholly-owned subsidiary of TWi Pharmaceuticals Inc., a Taiwan-based specialty pharmaceutical company focusing on the development and commercialization of "High Barrier to Entry" generic drugs. TWi focuses primarily on the development of Paragraph IV and high technical barrier generic drugs requiring strong science and technical know-how, as well as under-serviced mature molecules to meet market needs. For more information about TWi Corporate and "High Barrier to Entry" generics, please click here to visit www.twipharma.com.
Our goals are to expand our market presence in the United States as a strong industry partner, continue to identify, acquire, develop, license and launch technically challenging or mature molecule generic drugs and create sustainable profits through increased growth and value for our shareholders.
The key to TWi's success is based on 4 elements: Innovation, Integrity, Intelligence, and International. As a specialty pharmaceutical company, TWi thrives on overcoming technical challenges and innovations. With our unique ability to integrate various kinds of expertise from R&D all the way to commercialization, we believe that it is our social responsibility to provide high quality and affordable prescription drugs for patients worldwide.